 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
DUPONT'S CEO REVIEWS THE COMPANY'S STRATEGIC AND OPERATING PRIORITIES
Mar. 13, 2014
Source: DuPont news release
Speaking at the J. P. Morgan Investor Conference, DuPont Chair and Chief Executive Officer Ellen Kullman reviewed the company's plan to build a higher growth, higher value company for shareholders. Kullman outlined for investors DuPont's strategic and operational priorities that form the framework of its strategy.
"DuPont has been executing against its plan for more than five years and it's working," said Kullman. "We have positive momentum with strong positions in secular growth markets. Our portfolio of businesses enables us to leverage our science and market knowledge to create valuable solutions for customers and increased value for shareholders.
"DuPont has one of the broadest and deepest scientific capabilities of any enterprise," said Kullman. "An investment in DuPont is an investment in science, not simply for science's sake, but more as an engine for DuPont growth. Investors can expect that we will increase our rate of innovation and growth from our pipeline, capitalize on our global reach, and continue to deliver cost and asset productivity gains."
The company announced in October 2013 that it intends to separate its Performance Chemicals segment by a way of a spin-off to shareholders. Kullman told investors at today's conference that the project is on track for completion in the middle of next year.
DuPont's presentation slides and an audio replay are available on the Investor Center website at www.dupont.com.
|
|
|
|
|
